Medifast Inc(MED) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Oct 26 at 7:48 PM ET (Korea 10/27 08:48)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -3.69 | Insider Own | 6.03% | Shs Outstand | 11.2M | Perf Week | 0.67% |
| Market Cap | 0.14B | Forward P/E | - | EPS next Y | 75.65% | Insider Trans | 18.63% | Shs Float | 10.5M | Perf Month | -0.49% |
| Enterprise Value | -0.02B | PEG | - | EPS next Q | -0.12 | Inst Own | 73.29% | Short Float | 10.02% | Perf Quarter | 24.21% |
| Income | -0.04B | P/S | 0.45 | EPS this Y | -91.67% | Inst Trans | -8.55% | Short Ratio | 7.63 | Perf Half Y | 12.55% |
| Sales | 0.30B | P/B | 0.75 | EPS next 5Y | - | ROA | -16.08% | Short Interest | 1.05M | Perf YTD | 13.39% |
| Book/sh | 16.12 | P/C | 0.78 | EPS past 3/5Y | - | ROE | -20.69% | 52W High | -9.96% ($13.45) | Perf Year | -3.43% |
| Cash/sh | 15.43 | P/FCF | - | Sales past 3/5Y | -37.74% -16.22% | ROIC | -20.64% | 52W Low | 31.34% ($9.22) | Perf 3Y | -82.98% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -16409.29% | Gross Margin | 72.68% | Volatility(W/M) | 4.48% 2.96% | Perf 5Y | -94.02% |
| Dividend TTM | - | EV/Sales | -0.05 | Sales Y/Y TTM | -30.28% | Oper. Margin | -10.88% | ATR (14) | 0.42 | Perf 10Y | -70.48% |
| Dividend Ex-Date | 2023/9/18 | Quick Ratio | 4.32 | EPS Q/Q | -661.35% | Profit Margin | -13.64% | RSI (14) | 56.15 | Recom | 3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.82 | Sales Q/Q | -19.42% | SMA20 | 2.9% ($11.77) | Beta | 0.68 | Target Price | $12 |
| Payout | - | Debt/Eq | 0.11 | Earnings | 2026/10/26 | SMA50 | 1.56% ($11.92) | Rel Volume | 2.22 | Prev Close | $11.87 |
| Employees | 380 | LT Debt/Eq | 0.1 | EPS/Sales Surpr. | 45.71% 1.05% | SMA200 | 7.12% ($11.31) | Avg Volume(3M) | 0.14M | Price | $12.11 |
| IPO | 1993/12/30 | Option/Short | Yes/Yes | Trades | 2570 | Volume | 306,424 | Change | 2.02% |
🥗 Medifast (MED) is a U.S. weight management and health nutrition company. Through its flagship brand OPTAVIA, it offers programs that combine meal replacement products with coaching programs via a direct sales model. By linking its coach network with telehealth services, it has built a structure that manages both nutritional intake and lifestyle changes together.
Over the past 1 year, roughly in the middle
10% below its 1-year high.
Traded more than usual. That is 222% of its average volume.
MED has a sound balance sheet but weak earning power
Of every $100 in sales, $10.88 is lost.
Tap to view numbers
Growth has stalled
Earnings are expected to grow by -91.7% this year.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $45. Peers typically go for $41. Compared with its own 4-year average, it is 8436% pricier now.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Bought 5 years ago, your return today would be -94.0%. The S&P 500 did +68% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 73.3%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
SVAL iShares US Small Cap Value Factor ETF <0.01% 
FSCC Federated Hermes MDT Small Cap Core ETF <0.01% 
LQPE PEO AlphaQuest Thematic PE ETF <0.01% 
JPSE JPMorgan Diversified Return U.S. Small Cap Equity ETF <0.01% 
FNDA Schwab Fundamental U.S. Small Company ETF <0.01% Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
IHI iShares U.S. Medical Devices ETF 3.6B 
SBIO ALPS Medical Breakthroughs ETF 184M 
LFSC F/m Emerald Life Sciences Innovation ETF 115M 
BUZZ VanEck Social Sentiment ETF 90M 
SOCL Global X Social Media ETF 81M It ranks #8 of 13 in the industry
Based on market cap of $135M.
FAQ
What kind of company is MED?
MED belongs to the Consumer Cyclical sector and operates in the Personal Services industry.
What is the market cap of MED?
The market cap of MED is approximately $135M, ranking 4,303 within its sector.
What is the 52-week high and low for MED?
MED has recorded a 52-week high of $13.45 and a low of $9.22.
